Grants per year
Grants
- 1 Active
Search results
-
Active
Prot #CB8025-32251: IDEAL: A 52-Week, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Study Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Inc
Thaker, S. (PD/PI)
ICON Clinical Research Limited, Gilead Sciences, Inc
2/20/25 → 2/20/28
Project: Research project